Profile of:

Mireia Moreno


Full name: Mireia Moreno

Current country: Spain

Membership level: Full

Type of membership: Member

Number of publications: 16

Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO (2022)
https://pubmed.ncbi.nlm.nih.gov/35063018/

Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients (2021)
https://pubmed.ncbi.nlm.nih.gov/34876490/

Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32007930/

Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists (2020)
https://pubmed.ncbi.nlm.nih.gov/33146762/

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA (2020)
https://pubmed.ncbi.nlm.nih.gov/32251735/

Ultrasound Assessment of Psoriatic Onychopathy: A Cross-sectional Study Comparing Psoriatic Onychopathy with Onychomycosis (2019)
https://pubmed.ncbi.nlm.nih.gov/30281142/

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study (2019)
https://pubmed.ncbi.nlm.nih.gov/30953541/

Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study (2019)
https://pubmed.ncbi.nlm.nih.gov/31558361/

Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice (2019)
https://pubmed.ncbi.nlm.nih.gov/31535169/

Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database (2018)
https://pubmed.ncbi.nlm.nih.gov/30285828/

Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides) (2018)
https://pubmed.ncbi.nlm.nih.gov/29745878/

The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study (2018)
https://pubmed.ncbi.nlm.nih.gov/29786781/

Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29111261/

Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain (2017)
https://pubmed.ncbi.nlm.nih.gov/28389856/

Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs? (2016)
https://pubmed.ncbi.nlm.nih.gov/26812050/

A report of 4 years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis (2014)
https://pubmed.ncbi.nlm.nih.gov/24657116/